Bottom line
PHSYX vs IXJ: the short answer
PHSYX (Putnam Global Health Care Fund) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 78% by weight.
IXJ is cheaper at 0.38% vs 0.79% — a difference of $41 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +6.4% for IXJ (reporting dates differ).
Updated Nov 19, 2026
PHSYX vs IXJ side by side
| PHSYX | IXJ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.79% | 0.38% |
| Annual cost per $10k | $79 | $38 |
| 10-yr cost on $10k (prospectus) | $978 | $480 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +1.5% | +14.9% |
| 5-yr return (annualized) | +8.1% | +6.4% |
| 10-yr return (annualized) | +7.8% | +8.2% |
| Best quarter | — | +13.6% |
| Worst quarter | — | −11.8% |
| Net assets (fund) | $1.5B | $3.8B |
| Number of holdings | 115 | 124 |
| Portfolio turnover | 67% | 2% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of PHSYX's top 25 holdings also appear in IXJ's top 25.
| Holding | PHSYX | IXJ |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 10.93% |
| Johnson & Johnson | 8.46% | 7.04% |
| UnitedHealth Group, Inc. | 6.93% | 4.40% |
| AbbVie, Inc. | 6.05% | 5.12% |
| Novartis AG | 5.13% | 3.71% |
| Merck & Co., Inc. | 4.88% | 4.12% |
| AstraZeneca plc | 4.67% | 3.76% |
| Thermo Fisher Scientific, Inc. | 4.50% | 2.42% |
| Intuitive Surgical, Inc. | 4.04% | 1.83% |
| Sanofi SA | 3.23% | 1.18% |
| Roche Holding AG | 2.79% | 3.75% |
| CVS Health Corp. | 2.74% | 1.71% |
| Gilead Sciences, Inc. | 2.63% | 2.04% |
| McKesson Corp. | 2.14% | 1.18% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 1.64% |
Source: SEC Form N-PORT
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between PHSYX and IXJ?
Which is cheaper, PHSYX or IXJ?
Should I own both PHSYX and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.